BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11590472)

  • 1. [Malignant transformation of a choroidal nevus 6 years after brachytherapy of a non-contiguous choroidal melanoma - a case report and review of literature].
    Spraul CW; Gäckle HC; Lang GK
    Klin Monbl Augenheilkd; 2001 Sep; 218(9):626-31. PubMed ID: 11590472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tyndallometry for follow-up of iodine-125 brachytherapy of uveal malignant melanomas. Report of 2 patients].
    Nguyen NX; Küchle M; Strunk W
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):25-30. PubMed ID: 8965473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
    Isager P; Ehlers N; Urbak SF; Overgaard J
    Acta Oncol; 2006; 45(3):285-93. PubMed ID: 16644571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two differing presentations, treatments, and outcomes of malignant choroidal melanoma.
    Kearns C; Boyer S; Gay D
    Optometry; 2008 Jul; 79(7):365-70. PubMed ID: 18577493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
    Busse H; Müller RP
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bilateral uveal melanoma: a case report].
    Dunavoelgyi R; Dejaco-Ruhswurm I; Streubel B; Zehetmayer M
    Klin Monbl Augenheilkd; 2007 Nov; 224(11):858-61. PubMed ID: 18034402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
    Finger PT; Berson A; Szechter A
    Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study.
    Sobrin L; Schiffman JC; Markoe AM; Murray TG
    Ophthalmology; 2005 Oct; 112(10):1777-83. PubMed ID: 16095708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant transformation of a nevus of ota].
    Sellam R; Turut P; Dumont P; Madelain J
    Bull Soc Ophtalmol Fr; 1989 Feb; 89(2):319-22. PubMed ID: 2805210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetical study of a multifocal uveal melanoma.
    Filloy A; Caminal JM; Bruzual MC; Varela Mdel M; Gomà M
    Semin Ophthalmol; 2014 May; 29(3):163-5. PubMed ID: 23869977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
    Kreissig I; Rose D; Simader E
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brachytherapy of choroidal melanomas.
    Brady LW; Hernandez JC
    Strahlenther Onkol; 1992 Feb; 168(2):61-5. PubMed ID: 1542847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.